Vegetative Dysfunctions After Infections and Possibilities of Their Correction in the General Practice (Review of the Literature)

##plugins.themes.bootstrap3.article.main##

О. Б. Волошина

Abstract

The purpose of the review is to analyze current research on the treatment of autonomic dysfunctions (VD) after post-infections in outpatient practice. On the basis of the analysis of literature data, a review of national and foreign clinical studies on the diagnosis and treatment of VD was made. The review focuses on the differential diagnosis of functional disorders of the autonomic nervous system after transmitted infections with organic pathology, considering that the manifestations of VD after the transferred infections are polymorphic and characterized by dysfunctions of the cardiovascular, respiratory systems, fibromyalgia, poor adaptation of patients to physiological loads (clinortostatic, physical etc). In the review, there are publications that show that in the pathogenesis of VD after infections, not only impairment of the immune system, but also hypomanemia is important. A number of publications suggest that correction of deficiency of magnesium due to a magnesium-enriched diet often does not lead to an increase in magnesium in the body due to abnormal suction and/or increased excretion through the kidneys. Many studies convincingly demonstrate that the use of organic salts of magnesium (citrate, lactate, etc.) is accompanied by an increase in its content in the body and, accordingly, correction of functional disorders of the autonomic nervous system.

##plugins.themes.bootstrap3.article.details##

How to Cite
Волошина, О. Б. (2019). Vegetative Dysfunctions After Infections and Possibilities of Their Correction in the General Practice (Review of the Literature). Family Medicine, (1), 52–60. https://doi.org/10.30841/2307-5112.1.2019.172198
Section
Literature review
Author Biography

О. Б. Волошина, Odessa National Medical University

Olena B. Voloshyna,

Head of Department of General Practice

References

Bell E.J., McCarthey R.A., Riding M.H. / Coxsackie B viruses and myalgic encephalomyelitis / J. R. Soc. Med. 1988; 81: 329–31. https://doi.org/10.1177/014107688808100609

Joop p van de Merwe–Sjögren’s syndrome: information for patients and professionals: http://www.painful-bladder.org/pdf/ch6.pdf

Гороховская Г.Н., Чернецова Е.В., Петина М.М. Синдром хронической усталости: состояние проблемы // Новости медицины и фармации. 2010. 11-12 (331-332). Full text

Bounous G., Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome // Med. Hypotheses. 1999. Oct.; 53 (4): 347–9. https://doi.org/10.1054/mehy.1998.0780

Buchwald D. Post-viral Fatigue Syndrome / Ed. by R. Jenkins, J. Mowbray. 1991: P. 117–136.

Устинов А.В. Международная классификация болезней 11-го пересмотра: комментарий ВОЗ. Морион, 2018.

Pagani M., Ospedale L. Sacco. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system // Clin. Sci (Colch). 1999 Jan. 1; 96 (1): 117–125. https://doi.org/10.1042/cs0960117

Altura B.M. Basic biochemistry and physiology of magnesium: a brief review // Magnesium & Trace Elements. 1991; V. 10: P. 167–171.

Бурчинский С.Г. Проблема дефицита магния в организме: методы фармакологической коррекции // Здоровье Украины. – 2005. – С. 5–6. Full text

Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium / Manuel y Keenoy B., Moorkens G., Vertommen J., Noe M., Nuve J., De Leeuw I. // J. Am. Coll. Nutr. 2000 Jun.; 19 (3): 374–82. https://doi.org/10.1080/07315724.2000.10718934

Abraham G., Flechas J. Management of fibromyalgia: Rationale for the use of magnesium and malic acid // J. Nutr. Med. 1992; 3: 49–59. https://doi.org/10.3109/13590849208997961

Барна О.Н. Вегето-сосудистая дистония: комментарии специалиста: взгляд кардиолога // Медікс. Анти-Ейджинг. – 2009. – № 5. – С. 30–32.

Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care // Aust N Z J Psychiatry. 2005; 39 (9): 772–781. https://doi.org/10.1080/j.1440-1614.2005.01682.x

Вегетативная дистония в практике педиатра / И.Н. Захарова и др. // Медицинский совет. – 2015. – № 14. – С. 98–104. PDF

Белоконь Н.А., Кубергер М.Б. Болезни сердца и сосудов у детей: руководство для врачей. – М.: Медицина, 1987. – С. 136–190.

Заваденко Н.Н., Нестеровский Ю.Е. Клинические проявления и лечение синдрома вегетативной дисфункции у детей и подростков // Педиатрия. – 2012. – № 2 (9). – С. 92–102. PDF

Маколкин В.И. Вегетативная (автономная) дисфункция сердца / В.И. Маколкин / Кардиология: национальное руководство (под ред. Ю.Н. Беленкова, Р.Г. Оганова. – М.: ГЭОТАР-Медиа, 2007. – Гл. 22. – С. 1158–1168.

Хайтович Н.В. Лечение кардиальных проявлений вегетативной дисфункции (синдром солдатского сердца): [гипервентиляционный синдром, синдром усилия] // Здоров’я України ХХІ сторіччя: медична газета. 2015 березень. – № 1. Клінічна фармація. – С. 26–27. PDF

Швец Н.И., Бенца Т.М., Дидух Л.А. Нейроциркуляторная дистония: диагностика и лечение (лекция) // Семейная медицина. – 2009. – № 1. – С. 23–28.

Пат. 110442. Україна МПК Ф61В 5/02 (2006.01). Спосіб диференційної діагностики есенціальної артеріальної гіпертензії та нейроциркуляторної дистонії гіпертензивного типу / О.Б. Волошина, В.В. Саморукова, С.В. Бусел, І.С. Лисий, О.Р. Дукова, А.О. Чайка, Т.О. Дичко, В.О. Удовиця; власник Одеський національний медичний університет. № а2014 11463. Заявл. 21.10.14. Опубл. 25.12.2015, Бюл. № 24. Full text

Волошина О.Б., Саморукова В.В., Бусел С.В. Інформативність різних методик моніторування рівня артеріального тиску // Семейная медицина. – 2014. – № 4 (54). – С. 136–138.

Чичасова Н.В., Иголкина Е.В. Терапия синдрома фибромиалгии на современном этапе // Современная ревматология. – 2014. – № 2. – С. 65–71. https://doi.org/10.14412/1996-7012-2014-2-76-82

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity / Wolfe F, Clauw DJ, Fitzcharles M-A et al. // Arthritis Care Res (Hoboken). 2010; 62(5): 600–10. https://doi.org/10.1002/acr.20140

Central sensitization in fibromyalgia? A systematic review on structural and functional brain VRI / Cagnie B, Coppieters I, Denecker S, et al. // Semin Arthritis Rheum. 2004; Aug;44(1):68–75. https://doi.org/10.1016/j.semarthrit.2014.01.001

Синдром вегетативной дисфункции у детей и подростков / Л.С. Чутко, Т.Л. Корнишина, С.Ю. Сурушкина и др. // Журнал неврологии и психиатрии. – 2018. № 1. http://dx.doi.org/10.17116/jnevro20181181143-49

Вейн А.М., Молдовану И.В. Нейрогенная гипервентиляция. – Кишинев, 1988. – С. 10–37.

Дараган Н.В., Чикина С.Ю. Гипервентиляционный синдром в практике врача пульмонолога: патогенез, клиника, диагностика // Пульмология. – 2011. – № 5. – С. 87–96. https://doi.org/10.18093/0869-0189-2011-0-5-87-96

Стресс и расстройства адаптации / Акарачкова Е.С., Котова О.В., Вершинина С.В., Рябоконь И.В. // Лечащий врач. – 2014. – № 6. – С. 61. Full text

Баринов А. Сегментарные механизмы формирования мышечного спазма, спастичности и хронизации боли // Врач. – 2012. – № 5. – С. 17–23. PDF

Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case-control study and review of the literature / Assarzadegan F. et al. // Int. Clin. Psychopharmacol. 2016 Sep;31(5):287–92. https://doi.org/10.1097/YIC.0000000000000130

Boyle N.B., Lawton C.L., Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress – a Systematic Review // Nutrients. 2017 Apr 26; 9(5). https://doi.org/10.3390/nu9050429

Rowe W.J. Correcting magnesium deficiencies may prolong life // Clin Interv Aging. 2012; 7: 51–54. https://dx.doi.org/10.2147%2FCIA.S28768

Schlingmann K.P., Konrad M., Seyberth H.W. Genetics of hereditary disorders of magnesium homeostasis // Pediatr Nephrol. 2004; 19: 13–25. https://doi.org/10.1007/s00467-003-1293-z

Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study / Huang J.H., Lu Y.F., Cheng F.C., Lee J.N., Tsai L.C. // Nutrition J. 2012. 11(1). P. 41. https://doi.org/10.1186/1475-2891-11-41

Vink R. Magnesium in the CNS: recent advances and developments // Magnes. Res. – 2016. – 29 (3). – P. 95–101. https://doi.org/10.1684/mrh.2016.0408

Ueshima K. Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences // Magnes Res. 2005; 18(4): 275–284. PDF

Magnesium. An update on physiological, clinical and analytical aspects / Saris N.E., Mervaala E., Karppanen H., Khawaja J.A., Lewenstam A. // Clin Chim Acta. 2000; 294:1–26. https://doi.org/10.1016/s0009-8981(99)00258-2

Naderi A.S.A., Reilly R.F.Jr. Hereditary etiologies of hypomagnesemia // Nature Clinical Practice Nephrology. 2008; 4: 80–89. https://doi.org/10.1038/ncpneph0680

Hypomagnesemic hypocalcemia in chronic renal failure / Torralbo A., Portoles .J, Perez A.J., Barrientos A. // Am J Kidney Dis. 1993; 21:167–171. https://doi.org/10.1016/s0272-6386(12)81088-2

Vink R, Byard RW. Alcohol intoxication may exacerbate the effects of blunt cranial trauma through changes in brain free magnesium levels // J Forensic Sci. 2012; 57: 979–82. https://doi.org/10.1111/j.1556-4029.2012.02108.x

Дефицит магния как проблема стресса и дезадаптации у детей / Громова О.А., Торшин И.Ю., Гришина Т.Р., Федотова Л.Э. // РМЖ. – 2012. – Т. 20, № 16. – C. 813–21. Full text

Altered emotionality, hippocampus-dependent performance and expression of NMDA receptor subunit mRNAs in chronically stressed mice / Costa-Nunes J, Zubareva O, Araújo-Correia M, Valença A, Schroeter CA, Pawluski JL, Vignisse J, Steinbusch H, Hermes D, Phillipines M, Steinbusch HM, Strekalova T. // Stress. 2014;17(1):108–116. https://doi.org/10.3109/10253890.2013.872619

Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits / Pochwat B, Szewczyk B, Sowa-Kucma M, Siwek A, Doboszewska U, Piekoszewski W, Gruca P, Papp M, Nowak G // Int J Neuropsychopharmacol. 2014;17(3): 393–405. https://doi.org/10.1017/S1461145713001089

Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment / Sartori SB, Whittle N, Hetzenauer A, Singewald N. // Neuropharmacology. 2012; 62(1): 304–312. https://doi.org/10.1016/j.neuropharm.2011.07.027

Marsden WN. Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression // Med Hypotheses. 2011; 77(4): 508–528. https://doi.org/10.1016/j.mehy.2011.06.021

Effectiveness of yoga for menopausal symptoms: a systematic review and metaanalysis of randomized controlled trials / Cramer H., Lauche R., Langhorst J., Dobos G. // Evid Based Complement Alternat Med. 2012: 863–905. https://doi.org/10.1155/2012/863905

Mishra N, Mishra VN. Exercise beyond menopause: Dos and Don’ts // J Midlife Health. 2011; 2(2): 51–56. https://dx.doi.org/10.4103%2F0976-7800.92524

Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies / Del Gobbo LC et al. // Am J Clin Nutr. 2013 Jul; 98(1): 160–73. https://dx.doi.org/10.3945%2Fajcn.112.053132

Dietary magnesium intake and the incidence of depression: a 20-year follow-up study / Yary T., Lehto S.M., Tolmunen T., Tuomainen T.-P., Kauhanen J. et al. // J. Affect. Disord. 2016. – 193. – Р. 94–98. https://doi.org/10.1016/j.jad.2015.12.056

Rodriguez-Moran M., Guerrero-Romero F. Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects A randomized double-blind controlled trial // Diabetes care 2003; 26:1147–1152. https://doi.org/10.2337/diacare.26.4.1147

Трисветова Е.Л. Магний в клинической практике // Рациональная фармакотерапия в кардиологии. – 2012. – № 8 (4). – С. 545–553.

Hoy S.M., Scott L.J., Wagstaff A.J. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser // Drugs. 2009; 69 (1): 123–36. https://doi.org/10.2165/00003495-200969010-00009

Chiladakis J, Stathopoulos C, Davlouros P, et al. Intravenous magnesium sulphate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol. 2001;79:287–291. https://doi.org/10.1016/s0167-5273(01)00450-8

Davey M.J., Teubner D.A. Randomized controlled trial of magnesium sulfate in addition to usual care, for rate control in atrial fibrillation // Annals of Emergency Medicine. 2005; 45: 347–353. https://doi.org/10.1016/j.annemergmed.2004.09.013

Давыдова С., Яровой С. Препараты магния в лечении и профилактике суправентрикулярных тахиаритмий у больных урологического профиля // Врач. – 2011. – № 9. – С. 44–49. PDF

Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias / Zehender M., Meinertz T., Faber T., et al. // J Am Coll Cardiol. 1997; 29: 1028–1034. https://doi.org/10.1016/s0735-1097(97)00053-3

Метаболический синдром и дефицит магния: особенности течения и лечения / Шилов А.М., Галанова А.С., Грязнов Д.А. и др. // Врач. – 2008. – № 9. – С. 44–48.

Пак Л.С. Значение магния в патогенезе и лечении больных пролапсом митрального клапана // Трудный пациент. – 2007. – № 5 (5). – С. 13–6.

Eby GA, Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis // Med Hypotheses. 2010; 74(4): 649–660. https://doi.org/10.1016/j.mehy.2009.10.051

Роль дефицита магния в формировании клинических проявлений стресса у женщин / Акарачкова Е.С., Шавловская О.А., Вершинина С.В., Котова О.В., Рябоконь И.В. // Проблемы женского здоровья. – 2013. – № 3 (8). – С. 25–32.

Role of magnesium supplementation in the treatment of depression: A randomized clinical trial / Tarleton E.K., Littenberg B., MacLean C.D., Kennedy A.G., Daley C // PLoS One. 2017 Jun 27. 12(6). e0180067. https://doi.org/10.1371/journal.pone.0180067

Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: A cytokine/neurogenic inflammation hypothesis // Am J Physiol 1992; 263: R734–7. https://doi.org/10.1152/ajpregu.1992.263.3.R734

Kramer JH, Phillips TM, Weglicki WB. Magnesium-deficiency-enhanced postischemic myocardial injury is reduced by substance P receptor blockade // J Mol Cell Cardiol. 1997; 29: 97–110. https://doi.org/10.1006/jmcc.1996.0255

Ranade V.V., Somberg J.C. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans // Am J Ther. 2001; 8 (5): 345–357. http://dx.doi.org/10.1097/00045391-200109000-00008

Changes in erythrocyte contents of potassium, sodium and magnesium and Na, K-pump activity after the administration of potassium and magnesium salts / Sriboonlue P., Jaipakdee S., Jirakulsomchok D., Mairiang E., Tosukhowong P., Prasongwatana V., Savok S. // J Med Assoc Thai. 2004; 87 (12): 1506–1512.

Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach / Coudray C, Rambeau M., Feillet-Coudray C., Gueux E., Tressol J.C., Mazur A., Rayssiguier Y // Magnes Res. 2005 Dec; 18 (4): 215–23.

Громова О.А., Торшин И.Ю. Гришина Т.Р.Мировой опыт применения цитрата магния в медицине // Трудный пациент. – 2010. – № 8. – С. 20–27. Full text

Zinc supplementation in oral rehydration solutions: experimental assessment and mechanisms of action / Altaf W., Perveen S., Rehman K.U., Teichberg S., Vancurova I., Harper R.G., Wapnir R.A. // J Am Coll Nutr. 2002; 21 (1): 26–32. https://doi.org/10.1080/07315724.2002.10719190

Bowel preparation for CT colonography: blinded comparison of magnesium citrate and sodium phosphate for catharsis / Borden Z.S., Pickhardt P.J., Kim D.H., Lubner M.G., Agriantonis D.J., Hinshaw J.L. // Radiology. 2010; 254 (1): 138–144. https://doi.org/10.1148/radiol.09090398

Effect of potassium-magnesium citrate on upper gastrointestinal mucosa / Gonzalez G.B., Pak C.Y, Adams-Huet B., Taylor R., Bilhartz L.E // Aliment Pharmacol Ther. 1998; 12 (1): 105–110. https://doi.org/10.1046/j.1365-2036.1998.00280.x

Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study / Walker A.F., Marakis G., Christie S., Byng M. // Magnes Res. 2003; 16 (3): 183–191.

Relationship between dietary and biochemical measures of nutritional status in HANES I data / Kerr G.R., Lee E.S., Lam M.K., Lorimor R.J., Randall E., Forthofer R.N., Davis M.A., Magnetti S.M. // Am J Clin Nutr. 1982; 35 (2): 294–307. https://doi.org/10.1093/ajcn/35.2.294

Reappraisal of the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rat. Effects of treatment with potassium citrate or the combination magnesium citrate and potassium citrate / Schmiedl A., Schwille P.O., Berg O.B., Markovic M., Dvorak O. // Urol Int. 1998; 61 (2): 76–85. https://doi.org/10.1159/000030293

Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis / Schwille P.O., Schmiedl A., Herrmann U., Fan J., Gottlieb D., Manoharan M., Wipplinger J. // Urol Res. 1999; 27 (2): 117–126. https://doi.org/10.1007/s002400050097

Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis / Ettinger B., Pak C.Y, Citron J.T., Thomas C., Adams-Huet B., Vangessel A. // J Urol. 1997; 158 (6): 2069–2073. https://doi.org/10.1016/s0022-5347(01)68155-2

Odvina C.V., Mason R.P., Pak C.Y Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate // Am J Ther. 2006; 13 (2): 101–108. https://doi.org/10.1097/01.mjt.0000149922.16098.c0

Pak C.Y. Correction of thiazide-induced hypomagnesemia by potassium-magnesium citrate from review of prior trials // Clin Nephrol. 2000; 54 (4): 271–275.

Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals // Magnes Res. 2001; 14 (4): 283–290.

Media calcification, low erythrocyte magnesium, altered plasma magnesium, and calcium homeostasis following grafting of the thoracic aorta to the infrarenal aorta in the rat-differential preventive effects of long-term oral magnesium supplementation alon / Schwille P.O., Schmiedl A., Schwille R., Brunner P., Kissler H., Cesnjevar R., Gepp H. // Biomed Pharmacother. 2003; 57 (2): 88–97. https://doi.org/10.1016/S0753-3322(02)00343-8

The effect of oral magnesium therapy on visual field and ocular blood flow in normotensive glaucoma / Aydin B., Onol M., Hondur A., Kaya M.G., Ozdemir H., Cengel A., Hasanreisoglu B. // Eur J Ophthalmol. 2010; 20 (1): 131–135. https://doi.org/10.1177/112067211002000118

The effects of magnesium prophylaxis in migraine without aura / Koseoglu E., Talaslioglu A., Gonul A.S., Kula M. // Magnes Res. 2008; 21 (2): 101–108. http://doi.org/10.1684/mrh.2008.0132

Magnesium and acute mountain sickness / Dumont L., Mardirosoff C., Soto-Debeuf G., Tassonyi E. // Aviat Space Environ Med. 1999; 70 (6): 625.

Young G.L. Interventions for leg cramps in pregnancy // Cochrane Database Syst Rev. 2002; 1: D000121. https://doi.org/10.1002/14651858.CD000121

Choice of laxatives and colonoscopic preparation in pregnant patients from the viewpoint of obstetricians and gastroenterologists / Vinod J., Bonheur J., Korelitz B.I., Panagopoulos G // World J Gastroenterol. 2007; 13(48): 6549–6552. https://doi.org/10.3748/wjg.v13.i48.6549

Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women / Aydin H., Deyneli O., Yavuz D., Gozu H., Mutlu N., Kaygusuz I., Akalin S // Biol Trace Elem Res. 2010; 133 (2): 136–43. https://doi.org/10.1007/s12011-009-8416-8

Randomised, crossover, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps / Roffe C., Sills S., Crome P., Jones P. // Med Sci Monit. 2002; 8 (5): CR. 326–330. PDF

Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study / Bede O., Suranyi A., Pinter K., Szlavik M., Gyurkovits K // Magnes Res. 2003; 16 (4): 262–270.

The role of the correction of the hypomagnesemia in restorative treatment of patient with arterial hypertension and concomitant chronic obstructive pulmonary disease / I. Lysyi, O. Voloshyna, T. Dychko, O. Dukova, L. Kovalchuk, V. Samorukova, V. Zbitnieva // Metabolic syndrome and other categories of dysmetabolism: proceedings of the Republican scientific and practical conference with international participation: abstracts, 13 Apr 2018. Tashkent. – P. 133.

Магнікум: Інструкція до застосування /UA/7038/01/01 від 13.05.2017. /Наказ МОЗ: № 516 від 13.05.2017. Full text

Вплив Магне-В6 на вегетативний гомеостаз і психоемоційний статус при вегетативній дисфункції у дітей / В.Г. Майданник, Н.М. Кухта, І.О. Мітюряєва та ін. // Здоров’я України. Педіатрія. 2010, квітень. – С. 1–3. PDF

Магнікум-антистрес: Інструкція до застосування /Наказ МОЗ: № UA/16534/01/01 від 11.01.2018. Наказ № 48 від 11.01.2018. Full text